Animal Drug Compounding Market
Animal Drug Compounding Market Analysis by CNS Agents, Anti-infective Agents, Hormones & Substitutes, and Anti-inflammatory Agents from 2024 to 2034
Analysis of Animal Drug Compounding Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Animal Drug Compounding Market Outlook (2024 to 2034)
The global animal drug compounding market size is projected to increase from a valuation of US$ 2.32 billion in 2024 to US$ 5.03 billion by 2034-end. Worldwide Demand for animal drug compounding solutions is forecasted to rise at a CAGR of 8% through 2034. The market represents a crucial segment within the veterinary pharmaceutical industry, offering personalized medication solutions for various animal species.
The landscape of animal drug compounding revolves around customization, allowing veterinarians to address specific health concerns that may not be adequately covered by commercially available animal antibiotic medications. This personalized approach ensures dosage adjustments, formulation modifications, and even flavor enhancements to meet the unique requirements of diverse animal species.
Animal drug compounding encompasses a wide array of applications across different animal types, including companion animals (such as dogs, cats, and exotic pets) and livestock (such as horses, cows, and poultry). It addresses a multitude of health conditions, ranging from pain management, dermatological issues, and behavioral problems, to addressing allergies and chronic illnesses.
Key Market Growth Drivers
- Rise in pet ownership worldwide has driven the demand for specialized veterinary medications. Pet owners seek tailored treatments that cater precisely to the health needs of their animal companions.
- Continuous advancements in veterinary diagnostics and treatment methodologies have expanded the need for more effective and personalized medications.
- Commercially available drugs may not always align with the specific requirements of individual animals. This has led to an increase in the demand for compounded medications that offer customization in dosage, formulation, and administration.
- Veterinarians are increasingly recognizing the value of compounded medications in addressing specific health issues that cannot be adequately addressed by commercially available drugs. This acknowledgment has spurred the adoption of compounding practices within the veterinary community.
| Report Attributes | Details |
|---|---|
| Animal Drug Compounding Market Size (2023A) | US$ 2.15 Billion |
| Estimated Market Value (2024E) | US$ 2.32 Billion |
| Forecasted Market Value (2034F) | US$ 5.03 Billion |
| Global Market Growth Rate (2024 to 2034) | 8% CAGR |
| North America Market Share (2034F) | 65.7% |
| East Asia Market Growth Rate (2024 to 2034) |
8% CAGR |
| Oral Route of Administration Segment Share (2024E) | 78.9% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is Popularity of Animal Drug Compounding Surging?
“Increasing Awareness among Pet Owners about Personalized Animal Medication”
Heightened consciousness among pet owners regarding the health and well-being of their pets fuels the demand for personalized medications. Owners increasingly seek treatments tailored to address specific health conditions afflicting their pets, often unmet by mass-produced pharmaceuticals. They are more inclined towards solutions that offer precise dosages, alternative forms, and unique flavors that enhance compliance and efficacy.
Rising awareness about pet healthcare is bolstered by readily available information through various platforms, encouraging pet owners to actively participate in the healthcare decisions of their pets. Veterinarians, aligning with this trend, recommend compounded medications as an ideal solution to cater to individual pet needs.
“Growing Need for Personalized Medical Care and Tailored Compounded Drugs”
Demand for customization arises due to the inherent limitations of commercially available medications in meeting diverse and specific animal health requirements. Pets, like humans, have varying sensitivities, allergies, or unique health conditions that necessitate tailored pharmaceutical solutions. Compounded medications address these limitations by allowing flexibility in dosage strengths, formulation types, and flavors, catering precisely to individual animal needs.
Veterinarians, acknowledging these limitations, turn to compounding pharmacies to access customized medications that can be altered to suit specific conditions or preferences. The ability to customize medications not only enhances treatment efficacy but also plays a pivotal role in ensuring compliance and ease of administration, contributing significantly to the animal drug compounding market growth.
What Do Animal Drug Compounding Providers Need to Watch Out For?
“Complexities Involved in Ensuring Consistent Quality and Safety of Compounded Medications”
Compounding pharmacies, unlike conventional pharmaceutical manufacturers, produce customized medications in smaller batches, often tailored to the specific needs of individual animals. This customization process presents challenges in maintaining standardized production protocols. Variations in compounding methods, sourcing of raw materials, equipment, and environmental factors can affect the quality and potency of the final compounded product.
Ensuring uniformity and stability across different batches becomes challenging, leading to potential inconsistencies in the efficacy and safety of medications. The lack of standardized regulations specifically tailored to compounding pharmacies adds to the complexity. While regulatory bodies offer guidelines, adherence and enforcement of these guidelines may vary, resulting in disparities in quality control measures among different compounding facilities.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How Can Start-ups Make a Mark in This Competitive Market?
“Strong Emphasis on Technological Innovation and Regulatory Compliance”
Start-ups can invest in cutting-edge technologies such as 3D printing for precise dosage formulations and advanced drug delivery systems, enhancing the customization and efficacy of compounded medications. Forging strategic partnerships and collaborations within the veterinary community proves instrumental. Aligning with veterinarians, animal hospitals, and clinics enables start-ups to understand market needs better and gain access to a wider customer base.
Ensuring adherence to stringent regulatory standards instills trust among consumers and veterinarians, positioning start-ups as reliable and compliant entities in the market. A customer-centric approach is essential, offering exceptional service, personalized solutions, and responsive customer support.
Country-wise Insights
Animal drug compounding market trends are shaped by several country-specific factors. Developed countries with higher pet ownership rates tend to have a more mature market for compounded medications. Emerging economies such as East Asia are witnessing a growing demand for personalized veterinary medications due to increasing disposable incomes and a rising focus on pet health.
Why are Animal Drug Compounding Providers Thriving in the United States?
“Combination of Strong Pet Ownership Culture and Advancements in Veterinary Medicine”
| Attribute | United States |
|---|---|
| Segment Value (2024E) | US$ 1.33 Billion |
| Growth Rate (2024 to 2034) | 8.2% CAGR |
| Projected Value (2034F) | US$ 2.92 Billion |
The United States stands as a primary catalyst and a major contributor to the global animal drug compounding market size. The United States boasts a robust culture of pet ownership, with a substantial portion of households having companion animals. This deep-rooted attachment to pets drives the demand for specialized veterinary medications that cater precisely to individual animal needs, fostering a substantial market for compounded drugs.
The country’s veterinary industry showcases significant advancements in medical technologies and treatment methodologies. This progressive approach to veterinary medicine fosters a growing awareness among both pet owners and veterinarians about the benefits of tailored medications. A stringent yet adaptable regulatory environment in the United States ensures quality control and safety measures, instilling confidence among consumers and veterinarians in the efficacy and reliability of compounded medications.
Why is Japan Seeing Increasing Demand for Animal Drug Compounding Products?
“Evolving Veterinary Pharmaceutical Landscape and Rising Demand for Specialized Medications”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 40 Million |
| Growth Rate (2024 to 2034) | 7.5% CAGR |
| Projected Value (2034F) | US$ 83 Million |
Inclination of Japan toward innovation and technology, coupled with a growing awareness of personalized veterinary care, lays a strong foundation for the expansion of this sector. The pet ownership culture has witnessed a notable upsurge, with an increasing number of households embracing companion animals as integral family members.
Shift in perception has led to a heightened demand for tailored medications that cater precisely to the unique health needs of pets. A progressive veterinary healthcare system, characterized by advanced diagnostic tools and a focus on preventive care, has spurred the need for specialized pharmaceutical solutions that address intricate health conditions not adequately covered by standard medications.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
The market caters to diverse categories, addressing the specific animal healthcare needs of different animal types. Companion animals, including dogs, cats, and exotic pets, drive a significant portion of the market demand. The livestock category, encompassing horses, cows, poultry, and other farm animals, accounts for a substantial segment. Each category demands tailored formulations and dosage forms, underscoring the importance of specialized compounded medications in veterinary care.
Which Route of Administration Account for High Animal Drug Compounding Industry Growth?
“Strong Preference for Ease of Administration and Non-invasive Nature of Oral Medications”
| Attribute | Oral Route of Administration |
|---|---|
| Segment Value (2024E) | US$ 1.83 Billion |
| Growth Rate (2024 to 2034) | 8.4% CAGR |
| Projected Value (2034F) | US$ 4.11 Billion |
The oral route of administration stands at the forefront due to its versatility, ease of preparation, and broad applicability across various animal species. Unlike other administration routes such as animal vaccine injections or transdermal patches, oral medications are relatively easier to compound, making them a preferred choice for veterinarians and pet owners alike. Animals tend to exhibit better acceptance and tolerance towards oral medications, particularly when compounded into flavored forms or mixed into food.
Oral administration increases palatability and enhances medication adherence, ensuring that the animals receive the prescribed treatment without resistance. Oral formulations offer flexibility in dosage adjustments and can be customized to suit the specific needs of individual animals, allowing for precise dosing and better control over treatment outcomes. The non-invasive nature of oral medications minimizes stress for both the animal and the pet owner during administration.
Competitive Landscape
Established pharmaceutical companies, compounding pharmacies, veterinary clinics, and start-ups form the core competitors in this landscape aiming to capture a dominant animal drug compounding market share. Prominent animal drug compounding manufacturers are Wedgewood Pharmacy, Triangle Compounding Pharmacy, Davis Islands Pharmacy, Custom Med Compounding Pharmacy, Central Compounding Center South, Wellness Pharmacy of Cary, Caringbah Compounding Pharmacy, Millers Pharmacy, Smith’s Pharmacy, Specialist Compounding Pharmacy Pte Ltd., and Tache Pharmacy.
The competitive landscape is influenced by factors such as product differentiation, quality control measures, regulatory compliance, and the ability to offer a diverse range of compounded medications catering to various animal species.
- Osceola Capital announced the formation of Revelation Pharma Corp. in March 2021, in conjunction with renowned businessman Jacob Beckel, to investigate investments and alliances in the pharmacy compounding market.
- In October 2022, Medisca announced plans to lease a separate 60,000-square-foot building in Plattsburgh, New York, to centralize its packaging and distribution business.
Segmentation of Animal Drug Compounding Market Research
-
By Product Type :
- CNS Agents
- Anti-infective Agents
- Hormones & Substitutes
- Anti-inflammatory Agents
- Others
-
By Animal Type :
- Companion Animals
- Livestock Animals
-
By Route of Administration :
- Oral
- Injectable
- Topical
- Others
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Global Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Impact Benchmark with Previous Crisis 3.1.1.1. Change in Demand 3.1.1.2. Before and After COVID-19 Crisis (Projected) 3.1.1.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.1.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.2. Impact on Market and Value (US$ Mn) 3.1.2.1. Likely Loss of Value in 2023 3.1.2.2. Mid-term and Long-term Forecasts 3.1.2.3. Quarter by Quarter Demand and Recovery Assessment 3.1.3. Anticipated Demand and Value Recovery Curve 3.1.3.1. Likelihood of U-Shape Recovery 3.1.3.2. Likelihood of L-Shape Recovery 3.1.4. Recovery Period Assessment by Key Countries 3.1.5. Recovery Assessment by Key Market Segments 3.1.6. Action Points and Recommendations for Suppliers 3.1.7. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Animal Type Development Trends 4. Market Background and Foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Animal Drug Compounding 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034 5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023 5.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Animal Type 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Animal Type, 2018 to 2023 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Animal Type, 2024 to 2034 6.3.1. Companion Animals 6.3.2. Livestock Animals 6.4. Market Attractiveness Analysis By Animal Type 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Product Type 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Product Type, 2018 to 2023 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product Type, 2024 to 2034 7.3.1. CNS Agents 7.3.2. Anti-infective Agents 7.3.3. Hormones & Substitutes 7.3.4. Anti-inflammatory Agents 7.3.5. Others 7.4. Market Attractiveness Analysis By Product Type 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Route of Administration 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By Route of Administration, 2018 to 2023 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Route of Administration, 2024 to 2034 8.3.1. Oral 8.3.2. Injectable 8.3.3. Topical 8.3.4. Others 8.4. Market Attractiveness Analysis By Route of Administration 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2023 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 10.3.1. By Country 10.3.1.1. United States 10.3.1.2. Canada 10.3.2. By Animal Type 10.3.3. By Product Type 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Animal Type 10.4.3. By Product Type 11. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Animal Type 11.3.3. By Product Type 11.3.4. By Route of Administration 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Animal Type 11.4.3. By Product Type 11.4.4. By Route of Administration 12. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. United Kingdom 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Animal Type 12.3.3. By Product Type 12.3.4. By Route of Administration 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Animal Type 12.4.3. By Product Type 12.4.4. By Route of Administration 13. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Animal Type 13.3.3. By Product Type 13.3.4. By Route of Administration 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Animal Type 13.4.3. By Product Type 13.4.4. By Route of Administration 14. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Animal Type 14.3.3. By Product Type 14.3.4. By Route of Administration 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Animal Type 14.4.3. By Product Type 14.4.4. By Route of Administration 15. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Animal Type 15.3.3. By Product Type 15.3.4. By Route of Administration 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Animal Type 15.4.3. By Product Type 15.4.4. By Route of Administration 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. Hoye's Pharmacy 17.3.1.1. Company Overview 17.3.1.2. Animal Type overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. Vertisis Custom Pharmacy 17.3.2.1. Company Overview 17.3.2.2. Animal Type overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Smith Caldwell Drug Store 17.3.3.1. Company Overview 17.3.3.2. Animal Type overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Sixth Avenue Medical Pharmacy 17.3.4.1. Company Overview 17.3.4.2. Animal Type overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Dougherty's Pharmacy 17.3.5.1. Company Overview 17.3.5.2. Animal Type overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Medisca Inc. 17.3.6.1. Company Overview 17.3.6.2. Animal Type overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Wedgewood Pharmacy 17.3.7.1. Company Overview 17.3.7.2. Animal Type overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. Triangle Compounding Pharmacy 17.3.8.1. Company Overview 17.3.8.2. Animal Type overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Davis Islands Pharmacy 17.3.9.1. Company Overview 17.3.9.2. Animal Type overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. Custom Med Compounding Pharmacy 17.3.10.1. Company Overview 17.3.10.2. Animal Type overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 17.3.11. Central Compounding Center South 17.3.11.1. Company Overview 17.3.11.2. Animal Type overview 17.3.11.3. SWOT Analysis 17.3.11.4. Key Developments 17.3.12. Wellness Pharmacy of Cary 17.3.12.1. Company Overview 17.3.12.2. Animal Type overview 17.3.12.3. SWOT Analysis 17.3.12.4. Key Developments 17.3.13. Caringbah Compounding Pharmacy 17.3.13.1. Company Overview 17.3.13.2. Animal Type overview 17.3.13.3. SWOT Analysis 17.3.13.4. Key Developments 17.3.14. Millers Pharmacy 17.3.14.1. Company Overview 17.3.14.2. Animal Type overview 17.3.14.3. SWOT Analysis 17.3.14.4. Key Developments 17.3.15. Smith’s Pharmacy 17.3.15.1. Company Overview 17.3.15.2. Animal Type overview 17.3.15.3. SWOT Analysis 17.3.15.4. Key Developments 17.3.16. Specialist Compounding Pharmacy Pte Ltd. 17.3.16.1. Company Overview 17.3.16.2. Animal Type overview 17.3.16.3. SWOT Analysis 17.3.16.4. Key Developments 17.3.17. Tache Pharmacy 17.3.17.1. Company Overview 17.3.17.2. Animal Type overview 17.3.17.3. SWOT Analysis 17.3.17.4. Key Developments 17.3.18. Chiron Compounding Pharmacy 17.3.18.1. Company Overview 17.3.18.2. Animal Type overview 17.3.18.3. SWOT Analysis 17.3.18.4. Key Developments 17.3.19. MEDS Canadian Compounding Pharmacy 17.3.19.1. Company Overview 17.3.19.2. Animal Type overview 17.3.19.3. SWOT Analysis 17.3.19.4. Key Developments 17.3.20. Aurora Compounding 17.3.20.1. Company Overview 17.3.20.2. Animal Type overview 17.3.20.3. SWOT Analysis 17.3.20.4. Key Developments 17.3.21. Pace Pharmacy 17.3.21.1. Company Overview 17.3.21.2. Animal Type overview 17.3.21.3. SWOT Analysis 17.3.21.4. Key Developments 17.3.22. Victoria Compounding Pharmacy 17.3.22.1. Company Overview 17.3.22.2. Animal Type overview 17.3.22.3. SWOT Analysis 17.3.22.4. Key Developments 17.3.23. Pratt’s Compounding Pharmacy 17.3.23.1. Company Overview 17.3.23.2. Animal Type overview 17.3.23.3. SWOT Analysis 17.3.23.4. Key Developments 17.3.24. People’s Choice Pharmacy 17.3.24.1. Company Overview 17.3.24.2. Animal Type overview 17.3.24.3. SWOT Analysis 17.3.24.4. Key Developments 18. Assumptions and Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Animal Type, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Animal Type, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Animal Type, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Route of Administration, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Animal Type, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Animal Type, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Animal Type, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Route of Administration, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Animal Type, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Animal Type, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Animal Type, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by Route of Administration, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Animal Type, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Animal Type, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Animal Type, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Animal Type, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Animal Type, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Animal Type, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by Route of Administration, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Animal Type, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Animal Type, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Animal Type, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Route of Administration, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Animal Type, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Animal Type, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Animal Type, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Product Type, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Product Type, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by Route of Administration, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by Route of Administration, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Route of Administration, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Animal Type, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Animal Type, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Animal Type, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Animal Type, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Animal Type, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Animal Type, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Animal Type, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Animal Type, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Animal Type, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Animal Type, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Animal Type, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Animal Type, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Animal Type, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Animal Type, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Animal Type, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Animal Type, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Animal Type, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Animal Type, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Animal Type, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Animal Type, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Animal Type, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Product Type, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Product Type, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by Route of Administration, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by Route of Administration, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by Route of Administration, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the value of the animal drug compounding market?
The global animal drug compounding market is estimated at US$ 2.32 billion in 2024.
What is the projected sales value for animal drug compounding solutions by 2034?
By 2034-end, worldwide sales of animal drug compounding solutions are forecasted to reach US$ 5.03 billion.
At what rate is the demand for animal drug compounding predicted to increase?
Demand for animal drug compounding is forecasted to rise at 8% CAGR over the next 10 years.
At what rate is the market in North America predicted to grow?
The market in North America is projected to expand at 8.2% CAGR from 2024 to 2034.
Which country in East Asia is a key market for animal drug compounding?
Japan is forecasted to account for 53.8% share of the East Asian market by 2034.
What is the expected growth rate for the market in the United States?
The market in the United States is predicted to expand at 8.2% CAGR over the next 10 years.
Animal Drug Compounding Market